Allspring Global Investments’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,927
Closed -$205K 2832
2023
Q3
$205K Buy
12,927
+5,505
+74% +$91.5K ﹤0.01% 1758
2023
Q2
$140K Buy
7,422
+4,388
+145% +$51.8K ﹤0.01% 1935
2023
Q1
$11.7K Sell
3,034
-8,036
-73% -$34.3K ﹤0.01% 2578
2022
Q4
$54.9K Sell
11,070
-242
-2% -$1.31K ﹤0.01% 2303
2022
Q3
$54K Sell
11,312
-7,226
-39% -$38.1K ﹤0.01% 2324
2022
Q2
$83K Sell
18,538
-172,858
-90% -$751K ﹤0.01% 2114
2022
Q1
$911K Sell
191,396
-3,577
-2% -$19.8K ﹤0.01% 1936
2021
Q4
$1.45M Buy
+194,973
New +$1.21M ﹤0.01% 1717

Other funds holding IMGN

Allspring Global Investments's IMGN Position: Q4 2023 in Review

Allspring Global Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 12,927 shares — an estimated $205K sold.

Allspring Global Investments first reported a position in IMGN in Q4 2021 and held it in 8 quarters. The position peaked at $1.45M in Q4 2021. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Allspring Global Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 12,927 Immunogen Inc shares in Q4 2023, an estimated $205K.
  • Allspring Global Investments first reported a position in Immunogen Inc in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Immunogen Inc position peaked at $1.45M in Q4 2021.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.